Cargando…

Identifying Alzheimer’s disease-related proteins by LRRGD

BACKGROUND: Alzheimer’s disease (AD) imposes a heavy burden on society and every family. Therefore, diagnosing AD in advance and discovering new drug targets are crucial, while these could be achieved by identifying AD-related proteins. The time-consuming and money-costing biological experiment make...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Tianyi, Hu, Yang, Zang, Tianyi, Cheng, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876080/
https://www.ncbi.nlm.nih.gov/pubmed/31760934
http://dx.doi.org/10.1186/s12859-019-3124-7
Descripción
Sumario:BACKGROUND: Alzheimer’s disease (AD) imposes a heavy burden on society and every family. Therefore, diagnosing AD in advance and discovering new drug targets are crucial, while these could be achieved by identifying AD-related proteins. The time-consuming and money-costing biological experiment makes researchers turn to develop more advanced algorithms to identify AD-related proteins. RESULTS: Firstly, we proposed a hypothesis “similar diseases share similar related proteins”. Therefore, five similarity calculation methods are introduced to find out others diseases which are similar to AD. Then, these diseases’ related proteins could be obtained by public data set. Finally, these proteins are features of each disease and could be used to map their similarity to AD. We developed a novel method ‘LRRGD’ which combines Logistic Regression (LR) and Gradient Descent (GD) and borrows the idea of Random Forest (RF). LR is introduced to regress features to similarities. Borrowing the idea of RF, hundreds of LR models have been built by randomly selecting 40 features (proteins) each time. Here, GD is introduced to find out the optimal result. To avoid the drawback of local optimal solution, a good initial value is selected by some known AD-related proteins. Finally, 376 proteins are found to be related to AD. CONCLUSION: Three hundred eight of three hundred seventy-six proteins are the novel proteins. Three case studies are done to prove our method’s effectiveness. These 308 proteins could give researchers a basis to do biological experiments to help treatment and diagnostic AD.